Prediction of 30-Day Morbidity and Mortality After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Use of an Artificial Neural Network.
Autor: | Scott AW; School of Medicine, University of Minnesota, Minneapolis, MN, USA., Amateau SK; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Leslie DB; Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Ikramuddin S; Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Wise ES; Department of Surgery, University of Minnesota, Minneapolis, MN, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | The American surgeon [Am Surg] 2024 Jun; Vol. 90 (6), pp. 1202-1210. Date of Electronic Publication: 2024 Jan 10. |
DOI: | 10.1177/00031348241227182 |
Abstrakt: | Background: Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is indicated primarily for unsatisfactory weight loss or gastroesophageal reflux disease (GERD). This study aimed to use a comprehensive database to define predictors of 30-day reoperation, readmission, reintervention, or mortality. An artificial neural network (ANN) was employed to optimize prediction of the composite endpoint (occurrence of 1+ morbid event). Methods: Areview of 8895 patients who underwent conversion for weight-related or GERD-related indications was performed using the 2021 MBSAQIP national dataset. Demographics, comorbidities, laboratory values, and other factors were assessed for bivariate and subsequent multivariable associations with the composite endpoint ( P ≤ .05). Factors considered in the multivariable model were imputed into a three-node ANN with 20% randomly withheld for internal validation, to optimize predictive accuracy. Models were compared using receiver operating characteristic (ROC) curve analysis. Results: 39% underwent conversion for weight considerations and 61% for GERD. Rates of 30-day reoperation, readmission, reintervention, mortality, and the composite endpoint were 3.0%, 7.1%, 2.1%, .1%, and 9.1%, respectively. Of the nine factors associated with the composite endpoint on bivariate analysis, only non-white race ( P < .001; odds ratio 1.4), lower body-mass index ( P < .001; odds ratio .22), and therapeutic anticoagulation ( P = .001; odds ratio 2.0) remained significant upon multivariable analysis. Areas under ROC curves for the multivariable regression, ANN training, and validation sets were .587, .601, and .604, respectively. Discussion: Identification of risk factors for morbidity after conversion offers critical information to improve patient selection and manage postoperative expectations. ANN models, with appropriate clinical integration, may optimize prediction of morbidity. Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
Databáze: | MEDLINE |
Externí odkaz: |